ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

<link med fakultaet med-detailseiten news-detail article rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv>

Most Recent Papers

Efficient Information Retrieval for Sensing via Continuous MeasurementPhys. Rev. X 13, 031012arXiv:2209.08777

Active hyperpolarization of the nuclear spin lattice: Application to hexagonal boron nitride color centers, Phys. Rev. B 107, 214307, arXiv:2010.03334

Driving force and nonequilibrium vibronic dynamics in charge separation of strongly bound electron–hole pairsCommun Phys 6, 65 (2023)arXiv:2205.06623

Asymptotic State Transformations of Continuous Variable ResourcesCommun. Math. Phys. 398, 291–351 (2023)arXiv:2010.00044

Spin-Dependent Momentum Conservation of Electron-Phonon Scattering in Chirality-Induced Spin SelectivityJ. Phys. Chem. Lett. 2023, 14, XXX, 340–346arXiv:2209.05323


Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm

Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924

Office: Building M26, room 4117

Click here if you are interested in applying to the group